Ikarian Capital’s MacroGenics MGNX Stock Holding History

Ikarian Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-523,500	Closed	-$7.71M	–	145
2024 Q1	$7.71M	Buy	+523,500	New	+$7.91M	0.84%	39
2021 Q4	–	Sell	-446,000	Closed	-$9.34M	–	220
2021 Q3	$9.34M	Buy	446,000 +146,000	+49%	+$3.52M	0.66%	42
2021 Q2	$8.06M	Buy	300,000 +100,000	+50%	+$2.93M	0.65%	44
2021 Q1	$6.37M	Buy	+200,000	New	+$4.86M	0.21%	104
2020 Q1	–	Sell	-150,000	Closed	-$1.63M	–	167
2019 Q4	$1.63M	Buy	+150,000	New	+$1.48M	0.26%	66

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ikarian Capital's MGNX Position: Q1 2026 in Review

Ikarian Capital held its MacroGenics (MGNX) position steady in Q1 2026 at 74,893 shares worth $216K. The position accounts for 0.02% of the portfolio, ranked #139.

Ikarian Capital first reported a position in MGNX in Q4 2019 and has held it in 17 quarters since. The position peaked at $15.9M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Ikarian Capital held 74,893 shares of MacroGenics worth $216K as of Q1 2026.
Ikarian Capital left its MacroGenics share count unchanged in Q1 2026.
MacroGenics made up 0.02% of Ikarian Capital's portfolio in Q1 2026, its #139 holding.
Ikarian Capital first reported a position in MacroGenics in Q4 2019 and has held it in 17 quarters since.
Ikarian Capital's MacroGenics position peaked at $15.9M in Q1 2021.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.